Pivotal trials behind 59 novel FDA approvals in 2015 and 2016, estimated median cost per patient

$41,117

USD per patient, US

“The clinical trials cost a median of $41,117 per patient and $3562 per patient visit.”

AJMC, More than 100-fold cost differences found for pivotal trials (September 2018), reporting Moore et al., JAMA Internal Medicine 2018, 2018-09

Kind of source

Peer-reviewed study

Read on

2026-11-06

Daily check

Quote found at the source on 2026-11-06

What to know

Costs are estimates from an industry cost-assessment tool for direct trial costs; median enrolment was 488 patients. PhRMA disputed the study for leaving out unsuccessful candidates.